CAS 2306406-71-1 Omramotide

Send Inquiry
CAS 2306406-71-1 Omramotide
Details
CAS: 2306406-71-1
Sequence: D-Phe-Cys-Tyr-D-Trp-Lys-(3-Pal)-Cys-Thr-NH₂ (cyclized via Cys2-Cys7 disulfide bridge, 3-Pal = 3-pyridylalanine)
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Pharmaceutical Peptides / SSTR3 Selective Somatostatin Receptor Agonist
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2306406-71-1 omramotide in China, also supports custom service. Welcome to wholesale bulk high quality cas 2306406-71-1 omramotide from our factory. Contact us for more details.

 

Product name CAS:2306406-71-1:Omramotide
Description Omramotide is a highly selective somatostatin SSTR3 receptor agonist. Subtype specificity is achieved via unnatural amino acid substitution. It is applied in somatostatin receptor subtype functional identification, neuroendocrine tumor subtyping and central nervous regulation mechanism research.
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₆₁H₇₂N₁₂O₁₁S₂
Molecular weight (Da) 1205.44
Terminal modification C-terminal amidation

 

Products Description

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
Omramotide Omramotide; SSTR3 selective agonist; CAS 2306406-71-1 High-selectivity SSTR3 agonist,Somatostatin subtype study,Neuroendocrine tumor subtyping,Central nervous regulation,Cyclic peptide stability,Unnatural amino acid modification D-Phenylalanine-cysteine-tyrosine-D-tryptophan-lysine-3-pyridylalanine-cysteine-threoninamide (cyclized via Cys2-Cys7 disulfide bridge) C₆₁H₇₂N₁₂O₁₁S₂ 1204.49 1205.44 Free amine, D-amino acid configuration Amidation 8

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-OMR001 white powder Store at -20℃, strictly protected from light, sealed and dry, aliquoted. **Strictly prohibited from strong reducing agents** Solid powder stable for 2 years at 2-8℃ sealed and dry; small amount of DMSO can be added to stock solutions for solubilization Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots. **Slightly soluble in water, small amount of DMSO or dilute acetic acid required for solubilization**. Disulfide bridge is highly sensitive to reducing agents and prone to cleavage. Pyridine ring and aromatic residues are light-sensitive and easily degraded Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-OMR001 Highly selective SSTR3 agonist with strong subtype specificity, applied in somatostatin receptor subtype function and tumor subtyping research Omramotide is a new-generation subtype-selective somatostatin analog. Introduction of 3-pyridylalanine substitution in the classic octapeptide cyclic backbone significantly alters receptor binding pocket matching, achieving highly selective agonism for SSTR3 receptor with extremely low affinity for other subtypes such as SSTR2 and SSTR5. SSTR3 activation inhibits adenylate cyclase, reduces intracellular cAMP levels, and mediates neurotransmitter release regulation, cell proliferation inhibition and other effects. This molecule serves as an exclusive tool peptide for somatostatin receptor subtype functional identification, neuroendocrine tumor receptor subtyping, and central nervous mood and cognition regulation research. It can be used to distinguish physiological and pathological effects mediated by different subtypes, and also as a lead molecule for subtype-targeted drug development. Somatostatin subtype research,Neuroendocrine tumor subtyping,Central nervous regulation study,Receptor function identification,Subtype-selective drug development,Tumor signaling pathway research Somatostatin Receptor 3 (SSTR3); cAMP/PKA signaling pathway; Neurotransmitter release regulatory pathway

Hot Tags: cas 2306406-71-1 omramotide, China cas 2306406-71-1 omramotide manufacturers, suppliers, factory, CAS 121062 08 6, CAS 129954 34 3, CAS 910463 68 2, Melanotan II, Selank, Semaglutide

Send Inquiry